Slide 1 Are We Nearing the Limits of Office-Based CV Prevention? Thomas G. Allison, PhD, MPH Slide 2 America the Beautiful? Slide 3 Continuum of CVD Prevention Public Health…

Slide 1 Selection of Antihypertensive Drug Slide 2 ACE Inhibitor AT 1 Antagonist AT 1 Antagonist Diuretic Ca ++ Antagonist Beta Blocker Alpha Blocker Drug of choice Dr. Rx…

Slide 1 Management of Hypertension Laura Fitzpatrick, MD, MPH Intern Academics Friday the 13 th, August 2004 Slide 2 Background The JNC VII guidelines are issued periodically…

Recent advances in the management of resistant hypertension Scope Resistant hypertension Introduction Prevalence Management Additional drug/combinations Newer therapies Conclusions…

Renal Disease Dr. George Mellotte The Kidneys Two bean-shaped organs, each the size of a fist. Weighing ~0.5% of total body weight 20% of Cardiac output goes to Kidney On…

Are ACE inhibitors protective in non-DM renal disease? Luka Pocivavsek Analysis of a Major Study Outline 2. Presentation of major findings in a paper addressing effect of…

William C. Cushman, MD, FACP, FAHA Veterans Affairs Medical Center, Memphis, TN For The ACCORD Study Group ACCORD Sponsor, Collaborators and Contributors Collaboration &…

William C. Cushman, MD, FACP, FAHA Veterans Affairs Medical Center, Memphis, TN For The ACCORD Study Group ACCORD Sponsor, Collaborators and Contributors Collaboration &…

DEBRA L. BYNUM, MD Hypertension in the Elderly Outline Defining Systolic Hypertension Risks of SH in older persons Preventing stroke, CHF, CV events, dementia Review of major…

Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford Disclosures No disclosures Hypertension…